Search Results | Cancer Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Abstract 944: Analysis of efficacy of receptor tyrosine kinase and immune checkpoint inhibitors and insights to potential combinatorial treatment strategies in cholangiocarcinomas

Jun Liu, Junning Cao, Guan Wang, Bingyang Hu, Chun Dai, Shengzhou Wang, Fei Xu, Qiang Xu, Shichun Lu

Cancer Res (2021) 81 (13_Supplement): 944.

DOI: https://doi.org/10.1158/1538-7445.AM2021-944

Published: 01 July 2021

View article

Journal Articles

Abstract 2522: Exploring the prognostic and predictive value of circulating tumor DNA in patients with advanced colorectal cancer and chemotherapy

Xiu Liu, Xuan Zhang, Kai Ou, Chelong Lu, Dong Zheng, Jun Liu, Qiang Xu, Lin Yang

Cancer Res (2021) 81 (13_Supplement): 2522.

DOI: https://doi.org/10.1158/1538-7445.AM2021-2522

Published: 01 July 2021

View article

Journal Articles

Abstract 398: Tumor mutational burden estimated by whole-exome sequencing across multiple cancer types

Fei Xu, Jinwang Wei, Xiaochen Zhang, Jun Liu, Chun Dai, Guan Wang, Qiang Xu

Cancer Res (2021) 81 (13_Supplement): 398.

DOI: https://doi.org/10.1158/1538-7445.AM2021-398

Published: 01 July 2021

View article

Journal Articles

SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS–STING Activation and Chemotherapeutic Sensitivity in Colon Cancer

Bin Wei, Lingyan Xu, Wenjie Guo, Yuanyuan Wang, Jingjing Wu, Xiaofei Li, Xiaomin Cai, Jinbo Hu, Meijing Wang, Qiang Xu, Wen Liu, Yanhong Gu

Cancer Res (2021) 81 (12): 3215–3228.

DOI: https://doi.org/10.1158/0008-5472.CAN-20-3738

Published: 15 June 2021

View article

Includes: Supplementary data

Journal Articles

Abstract LB-233: Analysis of personalised circulating tumour DNA to monitor recurrence and metastasis in multiple cancer types

Guan Wang, Jinwang Wei, Angela Wu, Chun Dai, Wending Sun, Xin Cai, Qiang Xu

Cancer Res (2019) 79 (13_Supplement): LB-233.

DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-233

Published: 01 July 2019

View article

Journal Articles

Abstract 618: Application of clinical whole-exome sequencing as a predictor of clinical benefit of PD1/PDL1 blockade in a prospective study of advanced cancer patients

Guan Wang, Cheng Chen, Jinwang Wei, Angela Wu, Chun Dai, Xiaoman Xu, Xin Cai, Qiang Xu

Cancer Res (2018) 78 (13_Supplement): 618.

DOI: https://doi.org/10.1158/1538-7445.AM2018-618

Published: 01 July 2018

View article

Journal Articles

Abstract LB-040: Application of clinical whole exome sequencing among larger scale advanced cancer patients in China

Qiang Xu, Guan Wang, Chun Dai, Cheng Chen, Xiaoman Xu, Haining Wang, Angela Wu, Jiping Wang

Cancer Res (2017) 77 (13_Supplement): LB-040.

DOI: https://doi.org/10.1158/1538-7445.AM2017-LB-040

Published: 01 July 2017

View article

Journal Articles

Abstract 688: Activating JAK1-S703I mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma patient-derived xenograft tumor models

Shuqun Yang, Chonglin Luo, Qingyang Gu, Qiang Xu, Hongye Sun, Ziliang Qian, Yexiong Tan, Hao Wu, Yuxin Qin, Yuhong Shen, Xiaowei Xu, Shu-Hui Chen, Chi-Chung Chan, Hongyang Wang, Mao Mao, Douglas D. Fang

Cancer Res (2015) 75 (15_Supplement): 688.

DOI: https://doi.org/10.1158/1538-7445.AM2015-688

Published: 01 August 2015

View article

Journal Articles

Abstract 2839: Antitumor activities of FGFR inhibitors in FGFR1-overexpressing hepatocellular carcinoma patient-derived xenograft tumor models

Douglas D. Fang, Bin Zhang, Weiguo Xu, Kang Yan, Qingyang Gu, Qiang Xu, Yexiong Tan, Hongye Sun, Qin Luo, Weifeng Mao, Chiho Li, Jiangpeng Liao, Guibai Liang, Shu-Hui Chen, Chi-Chung Chan

Cancer Res (2014) 74 (19_Supplement): 2839.

DOI: https://doi.org/10.1158/1538-7445.AM2014-2839

Published: 01 October 2014

View article

Journal Articles

Abstract 4668: A next generation sequencing assay to detect the fusion products of ALK, ROS1 and RET with any fusion partner genes and hotspot mutations in FFPE samples

Qiang Xu, Guan Wang, Bo Li, Maoxiang Qian, Douglas Fang, Lele Sun, Yundi Chen, Hongye Sun

Cancer Res (2014) 74 (19_Supplement): 4668.

DOI: https://doi.org/10.1158/1538-7445.AM2014-4668

Published: 01 October 2014

View article

Journal Articles

Abstract 2739: Genetic characterization of an extensive panel of patient-derived xenograft tumor models of hepatocellular carcinoma for preclinical development.

Douglas D. Fang, Qiang Xu, Yexiong Tan, Lei Chen, Hongye Sun, Qingyang Gu, Bin Zhang, Qin Luo, Shu-hui Chen, Hongyang Wang, Chi-Chung Chan

Cancer Res (2013) 73 (8_Supplement): 2739.

DOI: https://doi.org/10.1158/1538-7445.AM2013-2739

Published: 15 April 2013

View article

Journal Articles

Abstract LB-397: Deep sequencing of Xenografts and case-matched blood and primary tumors reveals a 20 folds enrichment of loss of heterozygosity versus somatic mutations suggesting LOH plays an ever important role in tumorigenesis

Qiang Xu, Guan Wang, Douglas D. Fang, Yibo Gao, Yundi Chen, lele Sun, Xuelan Yan, Ou Li, Quanyu Yang, Maoxiang Qian, Bin Zhang, Zhaoli Chen, Chi-Chung Chan, Hongye Sun, Jie He

Cancer Res (2012) 72 (8_Supplement): LB-397.

DOI: https://doi.org/10.1158/1538-7445.AM2012-LB-397

Published: 15 April 2012

View article

Journal Articles

Abstract 2351: Identification of somatic mutations in esophageal squamous cell carcinoma and corresponding xenograft by next-generation sequencing

Douglas D. Fang, Yibo Gao, Qiang Xu, Hongye Sun, Bin Zhang, Zhaoli Chen, Chi-Chung Chan, Jie He

Cancer Res (2012) 72 (8_Supplement): 2351.

DOI: https://doi.org/10.1158/1538-7445.AM2012-2351

Published: 15 April 2012

View article

Journal Articles

Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma

Cancer Res (2011) 71 (7): 2476–2487.

DOI: https://doi.org/10.1158/0008-5472.CAN-10-2585

Published: 31 March 2011

View article

Includes: Supplementary data

Journal Articles

Abstract 2735: Diagnosis of prostate cancer without tumor cells using differentially expressed genes in the tumor microenvironment

Zhenyu Jia, Yipeng Wang, Michael McClelland, Anne Sawyers, Huazhen Yao, Farahnaz Rahmatpanah, Xiao-Qin Xia, Qiang Xu, James Koziol, Philip Carpenter, Jessica Wang-Rodriquez, Anne Simoneau, Frank Meyskens, Manuel Sutton, Waldemar Lernhardt, Thomas Beach, Dan Mercola

Cancer Res (2010) 70 (8_Supplement): 2735.

DOI: https://doi.org/10.1158/1538-7445.AM10-2735

Published: 15 April 2010

View article

Journal Articles

Development of a RNA quality control assay for FFPE samples

Qiang Xu, Kahuku Oades, Jennifer Stowe, Neil Tedeschi, Lien Vo, Gordon Vansant, Michael Birrer, Laurent Ozbun, Joseph Monforte

Cancer Res (2008) 68 (9_Supplement): 3651.

Published: 01 May 2008

View article

NARROW

Abstract 944: Analysis of efficacy of receptor tyrosine kinase and immune checkpoint inhibitors and insights to potential combinatorial treatment strategies in cholangiocarcinomas

Abstract 2522: Exploring the prognostic and predictive value of circulating tumor DNA in patients with advanced colorectal cancer and chemotherapy

Abstract 398: Tumor mutational burden estimated by whole-exome sequencing across multiple cancer types

SHP2-Mediated Inhibition of DNA Repair Contributes to cGAS–STING Activation and Chemotherapeutic Sensitivity in Colon Cancer

Abstract LB-233: Analysis of personalised circulating tumour DNA to monitor recurrence and metastasis in multiple cancer types

Abstract 618: Application of clinical whole-exome sequencing as a predictor of clinical benefit of PD1/PDL1 blockade in a prospective study of advanced cancer patients

Abstract LB-040: Application of clinical whole exome sequencing among larger scale advanced cancer patients in China

Abstract 688: Activating JAK1-S703I mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma patient-derived xenograft tumor models

Abstract 2839: Antitumor activities of FGFR inhibitors in FGFR1-overexpressing hepatocellular carcinoma patient-derived xenograft tumor models

Abstract 4668: A next generation sequencing assay to detect the fusion products of ALK, ROS1 and RET with any fusion partner genes and hotspot mutations in FFPE samples

Abstract 2739: Genetic characterization of an extensive panel of patient-derived xenograft tumor models of hepatocellular carcinoma for preclinical development.

Abstract LB-397: Deep sequencing of Xenografts and case-matched blood and primary tumors reveals a 20 folds enrichment of loss of heterozygosity versus somatic mutations suggesting LOH plays an ever important role in tumorigenesis

Abstract 2351: Identification of somatic mutations in esophageal squamous cell carcinoma and corresponding xenograft by next-generation sequencing

Diagnosis of Prostate Cancer Using Differentially Expressed Genes in Stroma

Abstract 2735: Diagnosis of prostate cancer without tumor cells using differentially expressed genes in the tumor microenvironment

Development of a RNA quality control assay for FFPE samples

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only